Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 6:56 pm Sale | 2025-08-14 | 13G | ReShape Lifesciences Inc. RSLS | L1 Capital Global Opportunities Master Fund, Ltd. | 1,966 0.330% | -56,785 (-96.65%) | Filing History |
| 2025-08-14 2:01 pm Unchanged | 2025-06-30 | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-08-13 06:32 am Purchase | 2025-06-30 | 13G | ReShape Lifesciences Inc. RSLS | Ayrton Capital LLC | 20 0.000% | 20 (New Position) | Filing History |
| 2025-06-13 4:05 pm Purchase | 2025-06-09 | 13G | ReShape Lifesciences Inc. RSLS | L1 Capital Global Opportunities Master Fund, Ltd. | 58,750 9.850% | 58,750 (New Position) | Filing History |
| 2025-05-14 2:59 pm Purchase | 2025-03-31 | 13G | ReShape Lifesciences Inc. RSLS | Ayrton Capital LLC | 50,000 5.710% | 50,000 (New Position) | Filing History |
| 2025-05-12 12:11 pm Purchase | 2025-03-31 | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 50,000 5.700% | 46,554 (+1350.85%) | Filing History |
| 2025-04-04 12:00 pm Sale | 2025-02-18 | 13D | ReShape Lifesciences Inc. RSLS | Dominion Capital LLC | 253 0.760% | -530 (-67.71%) | Filing History |
| 2025-02-24 3:02 pm Purchase | 2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS | Leonite Fund I, LP | 2,000 6.100% | 2,000 (New Position) | Filing History |
| 2025-02-24 11:24 am Purchase | 2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS | FirstFire Global Opportunities Fund LLC | 2,000 6.100% | 2,000 (New Position) | Filing History |
| 2025-02-21 5:28 pm Purchase | 2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS | BIGGER CAPITAL FUND L P | 3,200 9.680% | 3,200 (New Position) | Filing History |
| 2025-02-21 10:33 am Purchase | 2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 3,446 9.900% | 3,446 (New Position) | Filing History |
| 2025-01-07 2:52 pm Purchase | 2024-12-27 | 13D | ReShape Lifesciences Inc. RSLS | Dominion Capital LLC | 783 9.900% | 783 (New Position) | Filing History |
| 2024-09-26 4:45 pm Sale | 2024-09-23 | 13G | ReShape Lifesciences Inc. RSLS | Schneid Yair | 374 8.374% | -50 (-11.84%) | Filing History |
| 2024-01-16 6:07 pm Purchase | 2024-01-05 | 13G | ReShape Lifesciences Inc. RSLS | Schneid Yair | 424 10.525% | 424 (New Position) | Filing History |
| 2023-03-17 5:01 pm Purchase | 2023-02-06 | 13D | ReShape Lifesciences Inc. RSLS | Matthew Joseph Nachtrab Revocable Trust 2014 | 23 27.700% | 23 (New Position) | Filing History |
| 2023-02-15 3:34 pm Purchase | 2023-02-06 | 13D | ReShape Lifesciences Inc. RSLS | FOLEY & LARDNER | 23 27.700% | 23 (New Position) | Filing History |
| 2023-02-14 1:24 pm Purchase | 2022-12-31 | 13G | ReShape Lifesciences Inc. RSLS | Armistice Capital, LLC | 4 4.990% | 4 (New Position) | Filing History |
| 2022-02-14 6:35 pm Purchase | 2021-12-31 | 13G | ReShape Lifesciences Inc. RSLS | Armistice Capital, LLC | 7 9.990% | 4 (+126.96%) | Filing History |
| 2022-02-14 06:15 am Purchase | 2010-02-28 | 13G | ReShape Lifesciences Inc. RSLS | INTERWEST PARTNERS X LP | 0 0.000% | 0 (New Position) | Filing History |
| 2021-06-30 06:16 am Unchanged | 2021-06-29 | 13G | ReShape Lifesciences Inc. RSLS | Armistice Capital, LLC | 3 9.990% | 0 (Unchanged) | Filing History |